Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Takeda Pharmaceutical (TAK) Total Non-Current Liabilities (2018 - 2025)

Historic Total Non-Current Liabilities for Takeda Pharmaceutical (TAK) over the last 9 years, with Q4 2025 value amounting to $33.5 billion.

  • Takeda Pharmaceutical's Total Non-Current Liabilities fell 892.04% to $33.5 billion in Q4 2025 from the same period last year, while for Dec 2025 it was $33.5 billion, marking a year-over-year decrease of 892.04%. This contributed to the annual value of $31.5 billion for FY2025, which is 1759.92% down from last year.
  • According to the latest figures from Q4 2025, Takeda Pharmaceutical's Total Non-Current Liabilities is $33.5 billion, which was down 892.04% from $35.3 billion recorded in Q3 2025.
  • Takeda Pharmaceutical's 5-year Total Non-Current Liabilities high stood at $56.3 billion for Q1 2021, and its period low was $31.5 billion during Q1 2025.
  • Moreover, its 5-year median value for Total Non-Current Liabilities was $38.0 billion (2024), whereas its average is $40.2 billion.
  • Per our database at Business Quant, Takeda Pharmaceutical's Total Non-Current Liabilities crashed by 2628.69% in 2022 and then surged by 455.22% in 2024.
  • Over the past 5 years, Takeda Pharmaceutical's Total Non-Current Liabilities (Quarter) stood at $48.9 billion in 2021, then dropped by 26.29% to $36.0 billion in 2022, then decreased by 2.42% to $35.2 billion in 2023, then increased by 4.55% to $36.8 billion in 2024, then dropped by 8.92% to $33.5 billion in 2025.
  • Its Total Non-Current Liabilities stands at $33.5 billion for Q4 2025, versus $35.3 billion for Q3 2025 and $34.3 billion for Q2 2025.